Preservation of the Blood Brain Barrier and Cortical Neuronal Tissue by Liraglutide, a Long Acting Glucagon-Like-1 Analogue, after Experimental Traumatic Brain Injury

GLP-1 improves neuropathology after murine cold lesion brain trauma

(2015) Brian DellaValle et al.   Annals of Clinical and Translational Neurology

Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury

(2014) Nigel H. Greig et al.   Alzheimers & Dementia

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

(2014) Anna Secher et al.   JOURNAL OF CLINICAL INVESTIGATION

Enriched Housing Enhances Recovery of Limb Placement Ability and Reduces Aggrecan-Containing Perineuronal Nets in the Rat Somatosensory Cortex after Experimental Stroke

(2014) Alexandre Madinier et al.   PLoS One

Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation through a Calcium and AMPK Dependent Mechanism

(2014) Nadia M. Krasner et al.   PLoS One

Blood gases and energy metabolites in mouse blood before and after cerebral ischemia: the effects of anesthetics

(2013) Tina M Schwarzkopf et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Neuroprotective Effects of Liraglutide for Stroke Model of Rats

(2013) Kenichiro Sato et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury

(2013) David Tweedie et al.   NEUROBIOLOGY OF DISEASE

Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease

(2013) Paula L. McClean et al.   NEUROPHARMACOLOGY

Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats

(2013) Katharine Eakin et al.   PLoS One

The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells

(2012) Aya Shiraki et al.   ATHEROSCLEROSIS

Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice

(2012) David Tweedie et al.   EXPERIMENTAL NEUROLOGY

Glucagon-Like Peptide-1 Decreases Intracerebral Glucose Content by Activating Hexokinase and Changing Glucose Clearance during Hyperglycemia

(2012) Michael Gejl et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Scriptaid, a Novel Histone Deacetylase Inhibitor, Protects Against Traumatic Brain Injury via Modulation of PTEN and AKT Pathway

(2012) Guohua Wang et al.   Neurotherapeutics

Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats

(2011) Vladimer Darsalia et al.   CLINICAL SCIENCE

Neuroprotective properties of GLP-1: theoretical and practical applications

(2011) Jens Juul Holst et al.   CURRENT MEDICAL RESEARCH AND OPINION

Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Provides Neuroprotection in Mice Transient Focal Cerebral Ischemia

(2011) Shinichiro Teramoto et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia

(2011) Choong Hyun Lee et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury

(2011) Adam Chodobski et al.   Translational Stroke Research

Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats

(2010) B. P. Cummings et al.   DIABETES

Reorganization of Motor Cortex after Controlled Cortical Impact in Rats and Implications for Functional Recovery

(2010) Mariko Nishibe et al.   JOURNAL OF NEUROTRAUMA

Treating Hyperglycemia in Neurocritical Patients: Benefits and Perils

(2010) Daniel A. Godoy et al.   Neurocritical Care

Emerging treatments for traumatic brain injury

(2009) Ye Xiong et al.   EXPERT OPINION ON EMERGING DRUGS

Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury

(2009) Na'ama A. Shein et al.   FASEB JOURNAL

Brain tissue oxygen monitoring in traumatic brain injury and major trauma: outcome analysis of a brain tissue oxygen–directed therapy

(2009) Pradeep K. Narotam et al.   JOURNAL OF NEUROSURGERY

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

(2009) Arne Astrup et al.   LANCET

Long-term outcome following traumatic brain injury: A comparison of subjective reports by those injured and their relatives

(2009) Kristy Draper et al.   NEUROPSYCHOLOGICAL REHABILITATION

Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury

(2009) Anna M.B. Heile et al.   NEUROSCIENCE LETTERS

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

(2009) Y. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Evolution of Post-Traumatic Neurodegeneration after Controlled Cortical Impact Traumatic Brain Injury in Mice and Rats as Assessed by the De Olmos Silver and Fluorojade Staining Methods

(2008) Edward D. Hall et al.   JOURNAL OF NEUROTRAUMA

Autophagy is activated and might protect neurons from degeneration after traumatic brain injury

(2008) Yan-Bo Zhang et al.   Neuroscience Bulletin

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease

(2007) Göran Bertilsson et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Glucose neurotoxicity

(2007) David R. Tomlinson et al.   NATURE REVIEWS NEUROSCIENCE